Clinical context
A 30-year-old man with major hemorrhage from a left thigh wound arrives at
13:10. The physician orders
tranexamic acid (TXA) 1 g IV over 10 minutes, then
1 g over 8 hours. The drug arrives at
15:55, which is
2 hours 45 minutes after injury. The correct action is to start the
10-minute loading dose immediately.
Why the 3-hour window matters
TXA is an antifibrinolytic agent. It works by blocking the conversion of plasminogen to plasmin, thereby stabilizing clots that have already formed. In trauma, hyperfibrinolysis contributes to ongoing bleeding and coagulopathy.
The survival benefit of TXA is time-dependent: early administration reduces bleeding deaths, but delayed administration loses benefit and may increase harm. The
3-hour threshold is the widely accepted therapeutic window derived from the CRASH-2 trial and incorporated into trauma resuscitation guidelines
[1][2].
At
15:55, the patient is still within that window, with only
15 minutes remaining before the
3-hour mark at
16:10.
Key point! The loading dose must be initiated now. Waiting even a few more minutes would push administration beyond the evidence-based window, after which TXA is generally avoided in trauma
[1][2].
Dose and administration
The standard trauma regimen is
1 g IV over 10 minutes as a loading dose, followed by
1 g infused over 8 hours. The loading dose achieves rapid therapeutic plasma concentration when bleeding is active. The maintenance infusion sustains antifibrinolytic effect during the early post-injury period.
Pushing the loading dose over 1 minute is unsafe because rapid IV administration of TXA can cause hypotension and other adverse effects. The ordered
10-minute infusion rate must be respected
[3].
Why the other options are incorrect
Option 1 suggests pushing the dose over
1 minute to save time. This violates safe administration practice. TXA is not given as a rapid IV push; the
10-minute infusion is the standard loading method
[3].
Option 2 suggests starting only the
8-hour infusion without the loading dose. This would fail to achieve prompt therapeutic levels during the critical early phase of hemorrhage. The loading dose is essential for rapid clot stabilization
[1][3].
Option 3 suggests holding the drug because benefit ends
2 hours after injury. This is factually incorrect. The established window is
3 hours, not
2 hours. At
2 hours 45 minutes, the patient remains eligible for TXA
[1][2].
Clinical decision-making in the emergency setting
The nurse must recognize that the clock starts at the time of injury, not at arrival or at the time the order is written. For this patient, injury occurred at
13:10. The drug arrives at
15:55. The elapsed time is
2 hours 45 minutes.
Watch out! The remaining time within the
3-hour window is only
15 minutes. The nurse should prepare and start the
10-minute loading infusion without delay.
Safety considerations
TXA is generally well tolerated, but thromboembolic events are a recognized risk, particularly with delayed administration or in patients with pre-existing thrombotic risk factors
[3]. The review by Lier et al. notes that the benefit-risk balance is most favorable when TXA is given early within the
3-hour window
[3]. Orthopedic trauma literature similarly supports early TXA use to reduce blood loss and transfusion requirements, while acknowledging ongoing debate about optimal timing and thromboembolic risk .
The nurse’s priority is to initiate the ordered loading dose of TXA 1 g IV over 10 minutes immediately, because the patient is still within the 3-hour therapeutic window, with only 15 minutes remaining. The subsequent
1 g over 8 hours infusion should follow as ordered.
References (research sources)
- [1]
Tranexamic Acid Timing and Mortality Impact After Trauma.Research articleAli A, Gruen RL, Bernard SA, Burns B, Forbes AB, Gantner DC (2026) · DOI: 10.1016/j.annemergmed.2025.06.609
- [2]
Tranexamic acid for trauma: optimal timing of administration based on the CRASH-2 and CRASH-3 trials.Research articleOsawa I, Goto T, Roberts I (2025) · DOI: 10.1093/bjs/znaf079
- [3]
Tranexamic Acid for Acute Bleeding in Severely Traumatized Patients: Mortality, Neurological Outcomes, and Thromboembolic Risk.Research articleLier H, Maegele M, Hossfeld B. (2026) · DOI: 10.3238/arztebl.m2026.0046